When to Consider Perimenopause: Clinical Decision Aid
For primary care clinicians. Based on NICE NG23 and NAMS 2022 Position Statement.
Female patient, age 35-58, presenting with unexplained or multisystem symptoms
Are vasomotor symptoms present?
Hot flashes, night sweats, cold flashes, or flushing
YES
Perimenopause is likely if age 45+.
NICE: diagnose clinically without blood tests in women over 45.
Perimenopause is likely if age 45+.
NICE: diagnose clinically without blood tests in women over 45.
NO
Proceed to assess other symptom clusters below.
Proceed to assess other symptom clusters below.
Are 2+ of these symptom clusters present?
Menstrual changes (irregular, heavier, lighter) | Cognitive (brain fog, memory) | Mood (anxiety, irritability, depression) | Sleep disruption | Joint pain/stiffness | Decreased libido
YES
Consider perimenopause. Especially if onset is recent and unexplained by other causes.
Consider perimenopause. Especially if onset is recent and unexplained by other causes.
NO / UNCERTAIN
Consider alternative diagnoses (thyroid, anemia, depression). Re-evaluate in 3-6 months if symptoms persist.
Consider alternative diagnoses (thyroid, anemia, depression). Re-evaluate in 3-6 months if symptoms persist.
Is the patient under 45?
YES, under 45
Check FSH (x2, 4-6 weeks apart) + estradiol.
Rule out thyroid (TSH), anemia (CBC), pregnancy.
Check FSH (x2, 4-6 weeks apart) + estradiol.
Rule out thyroid (TSH), anemia (CBC), pregnancy.
NO, 45+
Clinical diagnosis is sufficient per NICE NG23. Blood tests are not required for women over 45 with typical symptoms.
Clinical diagnosis is sufficient per NICE NG23. Blood tests are not required for women over 45 with typical symptoms.
When to test (FSH)
- Patient is under 45
- Premature ovarian insufficiency suspected (under 40)
- Diagnostic uncertainty
- Patient on hormonal contraception (consider 6-week washout)
Note: A single normal FSH does not exclude perimenopause. Levels fluctuate significantly.
When to refer to specialist
- Suspected POI (under 40)
- Complex HRT decisions (history of VTE, breast cancer, CVD)
- Treatment-resistant vasomotor symptoms
- Significant mood/psychiatric symptoms
- Abnormal uterine bleeding requiring investigation
Initial management considerations
- Validate symptoms and educate patient
- Discuss lifestyle modifications
- Consider HRT if appropriate (see HRT reference card)
- Screen for cardiovascular risk factors
- Assess bone health if early menopause
- Consider CBT for mood/vasomotor symptoms
Key clinical pearls
- Perimenopause can begin 7-10 years before final period
- Symptoms may present as seemingly unrelated complaints
- Regular periods do not exclude perimenopause
- 40% of perimenopause is missed on blood tests alone
- Average age of menopause is 51 (range 45-55)
References: NICE Guideline NG23: Menopause: diagnosis and management (updated 2024). NAMS 2022 Position Statement on Hormone Therapy. The Lancet Commission on Menopause (2024).
MARKABLE is a general wellness product. It is not a medical device and is not intended to diagnose, treat, cure, or prevent any disease.